World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
112
Citations
48825
World Ranking
810
National Ranking
493

Medicine

D-Index
116
Citations
50647
World Ranking
4347
National Ranking
2370

Nancy E. Kemeny publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nancy E. Kemeny sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 545 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nancy E. Kemeny D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy E. Kemeny sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Nancy E. Kemeny is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research encompasses a broad range of topics within medicine, with a particular focus on surgery, oncology, and hepatology.

The scientist's primary fields of study include:

  • Medicine

Within this broad domain, Kemeny has contributed extensively to several subfields:

  • Surgery
  • Oncology
  • Hepatology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine

The main topics of Kemeny's work illustrate a focused engagement with specific types of cancers and related medical conditions:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Organ Transplantation Techniques and Outcomes
  • Gallbladder and Bile Duct Disorders
  • Viral-associated cancers and disorders

The scientist has authored several recent papers demonstrating ongoing research activity. Notable publications include:

  • A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers, 2021, JNCI Journal of the National Cancer Institute
  • Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma, 2021, Hepatology
  • Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer, 2021, Clinical Cancer Research
  • Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study, 2020, Clinical Colorectal Cancer
  • Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment, 2022, European Journal of Cancer

Kemeny's frequent co-authors include:

  • T. Peter Kingham
  • William R. Jarnagin
  • Andrea Cercek
  • Jeffrey A. Drebin
  • Alice C. Wei

The scientist's work is regularly published in several prominent medical journals, with multiple contributions particularly in the following venues:

  • Annals of Surgical Oncology
  • HPB
  • Journal of Clinical Oncology
  • Journal of Surgical Oncology
  • Clinical Cancer Research

Best Publications

  • The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

    R.K. Portenoy;H.T. Thaler;A.B. Kornblith;J. McCarthy Lepore

  • ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

    Gershon Y. Locker;Stanley R Hamilton;Jules Harris;John M. Jessup

  • Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah

  • Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

    James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong

  • 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Robert C. Bast;Peter Ravdin;Daniel F. Hayes;Susan Bates

  • CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors

    Sergey V. Shmelkov;Jason M. Butler;Andrea T. Hooper;Adilia Hormigo

  • Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

    Nancy Kemeny;Ying Huang;Alfred M. Cohen;Weiji Shi

  • Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    Daniel F. Hayes;Daniel F. Hayes;Robert C. Bast;Christopher E. Desch;Herbert Fritsche

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Symptom prevalence, characteristics and distress in a cancer population

    R. K. Portenoy;H. T. Thaler;A. B. Kornblith;J. McCarthy Lepore

  • Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

    Nancy Kemeny;John Daly;Bonnie Reichman;Nancy Geller

  • Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    Rona Yaeger;Walid K. Chatila;Marla D. Lipsyc;Jaclyn F. Hechtman

  • Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

    P Piedbois;M Buyse;N Kemeny

  • Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study

    Leonard B. Saltz;Heinz-Josef Lenz;Hedy L. Kindler;Howard S. Hochster

  • Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment

    George A. Poultsides;Elliot L. Servais;Leonard B. Saltz;Sujata Patil

  • Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

    Maeve A. Lowery;Ryan Ptashkin;Emmet Jordan;Michael F. Berger

  • Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)

    Nancy E. Kemeny;Donna Niedzwiecki;Donna R. Hollis;Heinz-Josef Lenz

  • Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma

    Gregory D. Leonard;Baruch Brenner;Nancy E. Kemeny

  • Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

    J. A. Conti;N. E. Kemeny;L. B. Saltz;Ying Huang

  • SPECIAL ARTICLE Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    Daniel F. Hayes;Robert C. Bast;Christopher E. Desch;Nancy E. Kemeny

Frequent Co-Authors

Michael I. D’Angelica
Michael I. D’Angelica Memorial Sloan Kettering Cancer Center
William R. Jarnagin
William R. Jarnagin Memorial Sloan Kettering Cancer Center
Yuman Fong
Yuman Fong City Of Hope National Medical Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Peter J. Allen
Peter J. Allen Duke University
T. Peter Kingham
T. Peter Kingham Memorial Sloan Kettering Cancer Center
Philip B. Paty
Philip B. Paty Memorial Sloan Kettering Cancer Center
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always require a traditional MD pathway. Today, rn to bsn online programs are a practical option for registered nurses aiming to advance with greater flexibility and affordability. For those holding a non-nursing bachelor’s degree, accelerated non nursing bachelor's to msn online programs offer a direct route into advanced practice nursing roles.

If you’re looking for accessible entry points into the healthcare field, adn programs can help you start your nursing career quickly. In addition, allied health roles are in high demand and often require less schooling. Training at reputable medical billing and coding schools online can open doors to administrative and support positions that are vital to patient care.

Whether you seek hands-on clinical practice, administration, or a faster route to healthcare employment, a range of accredited online programs can suit your goals and lifestyle.

Best Scientists Citing Nancy E. Kemeny

Trending Scientists

Recently Published Articles